Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Looking to the Future of AD Treatment
Author(s):
Brett King, MD, of Yale School of Medicine, discusses the future of atopic dermatitis treatment.
In this video, taken at the at the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference being held from April 9 to 11, in Baltimore, Maryland, Brett King, MD, of Yale School of Medicine, discusses the future of atopic dermatitis treatment, noting that the addition of targeted agents is enabling better responses in patients.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Related Videos
Related Content
